推进登革热疫苗研发:挑战,创新和通往全球保护的道路
Ran Wang1,2,3, Bridget Kim3, Hridesh Mishra3
1Laboratory of Infection and Virology Beijing Pediatric Research Institute Beijing Children's Hospital Capital Medical University National Center for Children's Health Beijing China.
Pediatric investigation
|September 19, 2025
概括
开发有效的登革热疫苗面临诸如抗体依赖增强 (ADE) 等挑战. 本综述分析了当前的疫苗 (CYD-TDV,TAK-003,Butantan-DV) 以及全球登革热控制的未来研究需求.
科学领域:
- 医学昆虫学 医学昆虫学
- 疫苗学 疫苗学 疫苗学
- 全球健康 全球健康
背景情况:
- 登革热是全球主要的健康问题,影响了世界上近一半的人口.
- 开发一种有效的登革热疫苗是复杂的,因为诸如抗体依赖增强 (ADE),血清型特异性疗效和输送后勤等挑战.
研究的目的:
- 提供关于登革热疫苗开发的全面审查,涵盖历史和当前进展.
- 分析领先的登革热疫苗的有效性,安全性和局限性:CYD-TDV,TAK-003和Butan-DV.
- 确定未来的研究方向,以改善登革热疫苗策略.
主要方法:
- 文献审查和对登革热疫苗候选人的公布数据的分析.
- 检查临床试验结果和现实世界的疗效研究.
- 关于均衡的四价值保护和安全概况的疫苗性能评估.
主要成果:
- 目前的登革热疫苗具有不同的疗效和安全性,但在实现普遍保护方面存在局限性.
- 抗体依赖增强 (ADE) 仍然是一个影响疫苗有效性的重大问题.
- CYD-TDV,TAK-003和Butantan-DV代表了关键的进步,但需要进一步优化.
结论:
- 持续投资和全球合作对于推动登革热疫苗开发至关重要.
- 未来的研究应该专注于缓解ADE,探索新型疫苗平台,并根据特定地区定制配方.
- 将疫苗接种纳入全面的登革热预防战略对于全球控制至关重要.
更多相关视频
08:36Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
Published on: November 1, 2018
32.6K
07:06A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
Published on: April 10, 2018
9.1K
相关概念视频
Microorganisms in Medicine and Therapeutics
987
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
987
Vaccinations
51.3K
Overview
51.3K
Cross-reactivity
32.9K
Overview
32.9K
